author_facet Tessier, A
Vautrin, M
Prezado, Y
Deman, P
Renier, M
Brochard, T
Nemoz, C
Philibert, R
Bravin, A
Esteve, F
Balosso, J
Elleaume, H
Berkvens, P
Giraud, J
Adam, J
Tessier, A
Vautrin, M
Prezado, Y
Deman, P
Renier, M
Brochard, T
Nemoz, C
Philibert, R
Bravin, A
Esteve, F
Balosso, J
Elleaume, H
Berkvens, P
Giraud, J
Adam, J
author Tessier, A
Vautrin, M
Prezado, Y
Deman, P
Renier, M
Brochard, T
Nemoz, C
Philibert, R
Bravin, A
Esteve, F
Balosso, J
Elleaume, H
Berkvens, P
Giraud, J
Adam, J
spellingShingle Tessier, A
Vautrin, M
Prezado, Y
Deman, P
Renier, M
Brochard, T
Nemoz, C
Philibert, R
Bravin, A
Esteve, F
Balosso, J
Elleaume, H
Berkvens, P
Giraud, J
Adam, J
Medical Physics
SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
General Medicine
author_sort tessier, a
spelling Tessier, A Vautrin, M Prezado, Y Deman, P Renier, M Brochard, T Nemoz, C Philibert, R Bravin, A Esteve, F Balosso, J Elleaume, H Berkvens, P Giraud, J Adam, J 0094-2405 2473-4209 Wiley General Medicine http://dx.doi.org/10.1118/1.3612289 <jats:p>Purpose: Contrast‐enhanced stereotactic synchrotron radiation therapy (SSRT) is an innovative technique based on localized dose‐enhancement effects obtained by reinforced photoelectric absorption in the target. Medium energy monochromatic x‐rays (50 –100 keV) are used for irradiating tumors previously loaded with high‐Z elements. SSRT clinical trials are being prepared at the European Synchrotron Radiation Facility (ESRF). The first patients (scheduled in summer–autumn 2011) should be treated at 80 keV, with 10 conformational beams. A dry run has been performed using an anthropomorphic radiosurgery human head phantom (Computerized Imaging Reference Systems, Norfolk, VA, USA). Methods: The phantom was scanned on a dedicated CT‐scanner, with and without a 3 cm diameter latex balloon filled with 3 mg/ml of iodine located in the supratentorial brain area. The PTV as well as the OAR were then contoured. The fisrt patient should receive 5 Gy at the ESRF in one fraction followed by a 6 Gy fraction and two 11 Gy fractions at the university hospital under stereotactic conditions (6 MV). The treatment will be followed by a whole brain irradiation (30 Gy, 10 fractions of 3 Gy, 6 MV). The treatment plan for the conventional stereotactic and whole brain irradiations were performed respectively on the Brainlab‐IPlan system, and on the Varian‐Eclipse TPS. The contrast enhanced SSRT treatment plan is performed on the ESRF dedicated version of Isogray (Dosisoft, Cachan, France) that has been developed for our irradiation technique.Results: The treatment plan was then successfully evaluated (Isodoses, DVHs and ICRU points). The full treatment was then realized on the phantom. Dose verifications were performed using gafchromic films and nPaG polymer gel dosimetry as well as in vivo dosimetry. Conclusions: This contrast enhanced SSRT clinical trial “dry run” was the last step before the phase I/II trial and shows the feasibility and readiness of the whole treatment chain.</jats:p> SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report Medical Physics
doi_str_mv 10.1118/1.3612289
facet_avail Online
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExOC8xLjM2MTIyODk
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExOC8xLjM2MTIyODk
institution DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint Wiley, 2011
imprint_str_mv Wiley, 2011
issn 0094-2405
2473-4209
issn_str_mv 0094-2405
2473-4209
language English
mega_collection Wiley (CrossRef)
match_str tessier2011suet335contrastenhancedstereotacticsynchrotronradiationtherapyclinicaltrialsadryrunreport
publishDateSort 2011
publisher Wiley
recordtype ai
record_format ai
series Medical Physics
source_id 49
title SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
title_unstemmed SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
title_full SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
title_fullStr SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
title_full_unstemmed SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
title_short SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
title_sort su‐e‐t‐335: contrast‐enhanced stereotactic synchrotron radiation therapy clinical trials: a dry run report
topic General Medicine
url http://dx.doi.org/10.1118/1.3612289
publishDate 2011
physical 3564-3564
description <jats:p>Purpose: Contrast‐enhanced stereotactic synchrotron radiation therapy (SSRT) is an innovative technique based on localized dose‐enhancement effects obtained by reinforced photoelectric absorption in the target. Medium energy monochromatic x‐rays (50 –100 keV) are used for irradiating tumors previously loaded with high‐Z elements. SSRT clinical trials are being prepared at the European Synchrotron Radiation Facility (ESRF). The first patients (scheduled in summer–autumn 2011) should be treated at 80 keV, with 10 conformational beams. A dry run has been performed using an anthropomorphic radiosurgery human head phantom (Computerized Imaging Reference Systems, Norfolk, VA, USA). Methods: The phantom was scanned on a dedicated CT‐scanner, with and without a 3 cm diameter latex balloon filled with 3 mg/ml of iodine located in the supratentorial brain area. The PTV as well as the OAR were then contoured. The fisrt patient should receive 5 Gy at the ESRF in one fraction followed by a 6 Gy fraction and two 11 Gy fractions at the university hospital under stereotactic conditions (6 MV). The treatment will be followed by a whole brain irradiation (30 Gy, 10 fractions of 3 Gy, 6 MV). The treatment plan for the conventional stereotactic and whole brain irradiations were performed respectively on the Brainlab‐IPlan system, and on the Varian‐Eclipse TPS. The contrast enhanced SSRT treatment plan is performed on the ESRF dedicated version of Isogray (Dosisoft, Cachan, France) that has been developed for our irradiation technique.Results: The treatment plan was then successfully evaluated (Isodoses, DVHs and ICRU points). The full treatment was then realized on the phantom. Dose verifications were performed using gafchromic films and nPaG polymer gel dosimetry as well as in vivo dosimetry. Conclusions: This contrast enhanced SSRT clinical trial “dry run” was the last step before the phase I/II trial and shows the feasibility and readiness of the whole treatment chain.</jats:p>
container_issue 6Part15
container_start_page 3564
container_title Medical Physics
container_volume 38
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792334717682450432
geogr_code not assigned
last_indexed 2024-03-01T14:32:38.473Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=SU%E2%80%90E%E2%80%90T%E2%80%90335%3A+Contrast%E2%80%90Enhanced+Stereotactic+Synchrotron+Radiation+Therapy+Clinical+Trials%3A+A+Dry+Run+Report&rft.date=2011-06-01&genre=article&issn=2473-4209&volume=38&issue=6Part15&spage=3564&epage=3564&pages=3564-3564&jtitle=Medical+Physics&atitle=SU%E2%80%90E%E2%80%90T%E2%80%90335%3A+Contrast%E2%80%90Enhanced+Stereotactic+Synchrotron+Radiation+Therapy+Clinical+Trials%3A+A+Dry+Run+Report&aulast=Adam&aufirst=J&rft_id=info%3Adoi%2F10.1118%2F1.3612289&rft.language%5B0%5D=eng
SOLR
_version_ 1792334717682450432
author Tessier, A, Vautrin, M, Prezado, Y, Deman, P, Renier, M, Brochard, T, Nemoz, C, Philibert, R, Bravin, A, Esteve, F, Balosso, J, Elleaume, H, Berkvens, P, Giraud, J, Adam, J
author_facet Tessier, A, Vautrin, M, Prezado, Y, Deman, P, Renier, M, Brochard, T, Nemoz, C, Philibert, R, Bravin, A, Esteve, F, Balosso, J, Elleaume, H, Berkvens, P, Giraud, J, Adam, J, Tessier, A, Vautrin, M, Prezado, Y, Deman, P, Renier, M, Brochard, T, Nemoz, C, Philibert, R, Bravin, A, Esteve, F, Balosso, J, Elleaume, H, Berkvens, P, Giraud, J, Adam, J
author_sort tessier, a
container_issue 6Part15
container_start_page 3564
container_title Medical Physics
container_volume 38
description <jats:p>Purpose: Contrast‐enhanced stereotactic synchrotron radiation therapy (SSRT) is an innovative technique based on localized dose‐enhancement effects obtained by reinforced photoelectric absorption in the target. Medium energy monochromatic x‐rays (50 –100 keV) are used for irradiating tumors previously loaded with high‐Z elements. SSRT clinical trials are being prepared at the European Synchrotron Radiation Facility (ESRF). The first patients (scheduled in summer–autumn 2011) should be treated at 80 keV, with 10 conformational beams. A dry run has been performed using an anthropomorphic radiosurgery human head phantom (Computerized Imaging Reference Systems, Norfolk, VA, USA). Methods: The phantom was scanned on a dedicated CT‐scanner, with and without a 3 cm diameter latex balloon filled with 3 mg/ml of iodine located in the supratentorial brain area. The PTV as well as the OAR were then contoured. The fisrt patient should receive 5 Gy at the ESRF in one fraction followed by a 6 Gy fraction and two 11 Gy fractions at the university hospital under stereotactic conditions (6 MV). The treatment will be followed by a whole brain irradiation (30 Gy, 10 fractions of 3 Gy, 6 MV). The treatment plan for the conventional stereotactic and whole brain irradiations were performed respectively on the Brainlab‐IPlan system, and on the Varian‐Eclipse TPS. The contrast enhanced SSRT treatment plan is performed on the ESRF dedicated version of Isogray (Dosisoft, Cachan, France) that has been developed for our irradiation technique.Results: The treatment plan was then successfully evaluated (Isodoses, DVHs and ICRU points). The full treatment was then realized on the phantom. Dose verifications were performed using gafchromic films and nPaG polymer gel dosimetry as well as in vivo dosimetry. Conclusions: This contrast enhanced SSRT clinical trial “dry run” was the last step before the phase I/II trial and shows the feasibility and readiness of the whole treatment chain.</jats:p>
doi_str_mv 10.1118/1.3612289
facet_avail Online
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExOC8xLjM2MTIyODk
imprint Wiley, 2011
imprint_str_mv Wiley, 2011
institution DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 0094-2405, 2473-4209
issn_str_mv 0094-2405, 2473-4209
language English
last_indexed 2024-03-01T14:32:38.473Z
match_str tessier2011suet335contrastenhancedstereotacticsynchrotronradiationtherapyclinicaltrialsadryrunreport
mega_collection Wiley (CrossRef)
physical 3564-3564
publishDate 2011
publishDateSort 2011
publisher Wiley
record_format ai
recordtype ai
series Medical Physics
source_id 49
spelling Tessier, A Vautrin, M Prezado, Y Deman, P Renier, M Brochard, T Nemoz, C Philibert, R Bravin, A Esteve, F Balosso, J Elleaume, H Berkvens, P Giraud, J Adam, J 0094-2405 2473-4209 Wiley General Medicine http://dx.doi.org/10.1118/1.3612289 <jats:p>Purpose: Contrast‐enhanced stereotactic synchrotron radiation therapy (SSRT) is an innovative technique based on localized dose‐enhancement effects obtained by reinforced photoelectric absorption in the target. Medium energy monochromatic x‐rays (50 –100 keV) are used for irradiating tumors previously loaded with high‐Z elements. SSRT clinical trials are being prepared at the European Synchrotron Radiation Facility (ESRF). The first patients (scheduled in summer–autumn 2011) should be treated at 80 keV, with 10 conformational beams. A dry run has been performed using an anthropomorphic radiosurgery human head phantom (Computerized Imaging Reference Systems, Norfolk, VA, USA). Methods: The phantom was scanned on a dedicated CT‐scanner, with and without a 3 cm diameter latex balloon filled with 3 mg/ml of iodine located in the supratentorial brain area. The PTV as well as the OAR were then contoured. The fisrt patient should receive 5 Gy at the ESRF in one fraction followed by a 6 Gy fraction and two 11 Gy fractions at the university hospital under stereotactic conditions (6 MV). The treatment will be followed by a whole brain irradiation (30 Gy, 10 fractions of 3 Gy, 6 MV). The treatment plan for the conventional stereotactic and whole brain irradiations were performed respectively on the Brainlab‐IPlan system, and on the Varian‐Eclipse TPS. The contrast enhanced SSRT treatment plan is performed on the ESRF dedicated version of Isogray (Dosisoft, Cachan, France) that has been developed for our irradiation technique.Results: The treatment plan was then successfully evaluated (Isodoses, DVHs and ICRU points). The full treatment was then realized on the phantom. Dose verifications were performed using gafchromic films and nPaG polymer gel dosimetry as well as in vivo dosimetry. Conclusions: This contrast enhanced SSRT clinical trial “dry run” was the last step before the phase I/II trial and shows the feasibility and readiness of the whole treatment chain.</jats:p> SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report Medical Physics
spellingShingle Tessier, A, Vautrin, M, Prezado, Y, Deman, P, Renier, M, Brochard, T, Nemoz, C, Philibert, R, Bravin, A, Esteve, F, Balosso, J, Elleaume, H, Berkvens, P, Giraud, J, Adam, J, Medical Physics, SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report, General Medicine
title SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
title_full SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
title_fullStr SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
title_full_unstemmed SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
title_short SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
title_sort su‐e‐t‐335: contrast‐enhanced stereotactic synchrotron radiation therapy clinical trials: a dry run report
title_unstemmed SU‐E‐T‐335: Contrast‐Enhanced Stereotactic Synchrotron Radiation Therapy Clinical Trials: A Dry Run Report
topic General Medicine
url http://dx.doi.org/10.1118/1.3612289